Advertisement

Spinal Tech

Aspen Medical Products named Steve Paul president and separated its combined CEO and president position into two executive roles. Jim Cloar will continue to serve as CEO, while Mr. Paul will assume responsibility for many of the company’s day-to-day operations,…

Revenue at Aurora Spine fell 18.7% to $3.66 million in the second quarter of 2026, from $4.50 million during the same period in 2025. “The second-quarter results were disappointing,” CEO Trent Northcutt said in an Aug. 27 news release, pointing…

DeGen Medical issued a statement in support of the new CMS inpatient classification codes for custom-made lumbar fusion devices set to take effect in fiscal 2027, according to an Aug. 25 news release from the devicemaker. “CMS has now established…

The FDA granted 510(k) clearance to Spineart’s Perla TL application for use with eCential Robotics’ Op.n Navigation and Robotic-Assisted Platform. The clearance expands the application’s use with the Op.n platform to robotic-assisted workflows, according to an Aug. 26 news release.…

The North American Spine Society has revised its coverage recommendations for spinal cord stimulation. The recommendations provide evidence-based guidance supporting coverage of spinal cord stimulation as a treatment for chronically painful spine conditions in patients who do not have surgical…

Advertisement

Robot-assisted knee replacement surgery was more precise than surgeon-only procedures but did not lead to better patient outcomes, according to a study published Aug. 20 in The Lancet. Researchers recruited 339 patients being treated by 33 surgeons at 10 hospitals…

SpineGuard has been granted a U.S. patent by the U.S. Patent and Trademark Office for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine. The technology uses…

Amplio Spine named Nomen Azeem, MD, chief clinical officer and founding chair of its advisory board. Dr. Azeem will direct the company’s clinical strategy and research programs and build its clinical governance structure, according to an Aug. 25 news release.…

The FDA has placed a clinical hold on Regenxbio’s gene therapy, RGX-121, for mucopolysaccharidosis II, also known as Hunter syndrome, after spinal MRIs turned up asymptomatic nodules or cystic masses in five participants in the Campsiite trial. The findings were…

Spinal Elements has launched Overwatch PCF, a posterior cervical fixation system. The system features polyaxial screws with 120 degrees of angulation and tulips that accept both 3.5 mm and 4.0 mm rods, according to an Aug. 18 LinkedIn post and…

Advertisement